Baldness Drugs Are Wall Street’s Next Goldmine
Drugmakers working on the next generation of male hair loss treatments are seeing soaring share prices, reminiscent of a similar pattern with GLP-1 innovations.
We haven't written up this one. Business of Fashion has the full story — the link below goes straight to it.